The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

Does walking count as exercise? Yes, walking is exercise, and experts across physical and mental health disciplines agree.

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

An official cause of death for actor Michelle Trachtenberg — best known for her roles in “Harriet the Spy,” “Gossip Girl,” ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

Once-daily orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with diabetes and ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at ...

Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist, significantly reduced hemoglobin A1c (HbA1c) in adults with type 2 diabetes (T2D) and inadequate glycemic control with diet ...

A once-daily oral GLP-1 conferred greater reductions in HbA1c and body weight than placebo among adults with type 2 diabetes, ...

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...

The cause of death for 39-year-old actress Michelle Trachtenberg has been revealed as related to diabetes complications, ...